Sionna Therapeutics (SION) EPS (Weighted Average and Diluted) (2024 - 2026)
Sionna Therapeutics' (SION) quarterly EPS (Weighted Average and Diluted) came in at -$0.6 in Q1 2026, up 3.23% year-on-year from -$0.58 in Q1 2025, and down 33.33% quarter-over-quarter from -$0.45 in Q4 2025.
Sionna Therapeutics (SION) EPS (Weighted Average and Diluted) (2024 - 2026) Analysis & Trends
Sionna Therapeutics has disclosed EPS (Weighted Average and Diluted) across 3 years of filings, most recently posting -$0.6 for Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.6, up 3.23% year-over-year; the trailing twelve-month figure through Mar 2026 was -$411.51 (up 84.87% YoY), and the FY2025 annual result was -$1.88, up 88.24% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.6 for Q1 2026 at Sionna Therapeutics, down from -$0.45 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.45 in Q4 2025 to a low of -$3840.0 in Q1 2024.
- The 3-year median for EPS (Weighted Average and Diluted) is -$3.18 (2024), against an average of -$774.55.
- Across the five-year window, EPS (Weighted Average and Diluted) jumped 99.98% in 2025 and climbed 3.23% in 2026, its largest moves.
- Sionna Therapeutics' EPS (Weighted Average and Diluted) stood at -$3.18 in 2024, then soared by 85.85% to -$0.45 in 2025, then plunged by 33.33% to -$0.6 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.6 (Q1 2026), -$0.45 (Q4 2025), and -$0.46 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 0.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -0.61 |
| 10 | Sionna Therapeutics | 1.61 Bn | 1.61 Bn | - | -0.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.60 |
| Dec 31, 2025 | -0.45 |
| Sep 30, 2025 | -0.46 |
| Jun 30, 2025 | -410.00 |
| Mar 31, 2025 | -0.62 |
| Dec 31, 2024 | -3.18 |
| Sep 30, 2024 | -5.67 |
| Jun 30, 2024 | -2,710.00 |
| Mar 31, 2024 | -3,840.00 |